Atlas Trials

Understanding Adaptive Immune Response After COVID-19 Vaccination Boosters to Improve Vaccination Strategies in Vulnerable Groups.

Clinical trial NCT06300853 · UNKNOWN

Trial details

NCT number
NCT06300853
Sponsor
IRCCS Sacro Cuore Don Calabria di Negrar
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19
Start date
2023-11-14
Primary completion
2025-11-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.